Related Experiment Video
Updated: Jan 28, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
4.2K
[Hypertrophic cardiomyopathy: current state of the problem]
P V Lednev1, A V Stonogin1, A V Lysenko1
1Petrovsky Russian Research Center for Surgery, Moscow, Russia.
Khirurgiia
|February 22, 2019
Summary
Hypertrophic cardiomyopathy (HCM) is reviewed, covering its epidemiology, pathophysiology, and treatments. Surgical intervention remains the preferred method for HCM, offering excellent outcomes with low risk.
Area of Science:
- Cardiology
- Internal Medicine
- Medical Research
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
- Understanding its epidemiology and pathophysiology is crucial for effective management.
- Current treatment strategies include medication and surgical options.
Purpose of the Study:
- To provide a comprehensive review of hypertrophic cardiomyopathy.
- To discuss the epidemiology, pathophysiology, and treatment modalities of HCM.
- To highlight the efficacy of surgical treatment for HCM.
Main Methods:
- Literature review of epidemiological data.
- Analysis of pathophysiological mechanisms in HCM.
- Evaluation of current medication and surgical treatment outcomes.
Main Results:
- Surgical treatment is identified as the primary therapeutic approach for HCM.
- The review covers key aspects of HCM epidemiology and pathophysiology.
- Medication and surgical interventions are discussed in detail.
Conclusions:
- Surgical treatment for hypertrophic cardiomyopathy yields excellent immediate and long-term results.
- Minimal risk is associated with surgical intervention in HCM patients.
- Surgical treatment is emphasized as the method of choice for managing HCM.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
467
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
467
01:30Cardiomyopathy II: Dilated Cardiomyopathy
549
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
549
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
519
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
519
01:29Cardiomyopathy V: Interprofessional Care
396
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
396
01:25Cardiomyopathy I: Introduction and Classification
588
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
588
01:29Cardiomyopathy VI: Nursing Management
348
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
348